Incretin hormones (GIP and GLP-1) play an important role in the pathophysiology (reduced incretin effect) and progression (given the deterioration of postprandial glycaemic control as a result of the reduced incretin effect) of type 2 diabetes. The gene discussed is GCG; the disease is type 2 diabetes mellitus.